<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05081310</url>
  </required_header>
  <id_info>
    <org_study_id>SVC001</org_study_id>
    <nct_id>NCT05081310</nct_id>
  </id_info>
  <brief_title>Cryoballoon Isolation of Superior Vena Cava in Paroxysmal Atrial Fibrillation</brief_title>
  <acronym>CISPAF</acronym>
  <official_title>Cryoballoon Isolation of Superior Vena Cava in Paroxysmal Atrial Fibrillation - a Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zagreb</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zagreb</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is still unresolved question whether isolation of superior vena cava (SVC) in&#xD;
      conjunction to conventional pulmonary vein isolation (PVI) improves outcomes in the treatment&#xD;
      of paroxysmal atrial fibrillation. The investigators are conducting a randomized study to&#xD;
      determine if SVC isolation (in addition to pulmonary vein isolation) with the cryoballoon&#xD;
      technology can improve freedom from atrial arrhythmias in one year follow up after the&#xD;
      ablation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Paroxysmal atrial fibrillation can be triggered by non-pulmonary vein foci, like the superior&#xD;
      vena cava. There are some older publications showing improved result in terms of freedom from&#xD;
      atrial tachycardias when electrical isolation of this vessel utilizing radiofrequency energy&#xD;
      is achieved. Recent retrospective studies showed that isolation of superior vena cava by the&#xD;
      means of cryoballoon technology is safe and feasible procedure. Furthermore, one&#xD;
      retrospective cohort study showed improved outcomes of SVC insolation + PVI versus PVI only&#xD;
      strategy. To our knowledge there is still no randomized data that compared SVC isolation +&#xD;
      PVI vs PVI only strategy when using cryoballoon technology.&#xD;
&#xD;
      The investigators want to determine if SVC isolation by the means of cryoballoon technology&#xD;
      in conjunction with PVI can improve the patients outcomes. Also, there will be focus on the&#xD;
      safety of the procedure, especially regarding the right sided phrenic nerve palsy. The&#xD;
      primary objective of the study is freedom from atrial arrhythmias defined by standard&#xD;
      postprocedural monitoring by ECG and Holter monitors. The investigators are conducting a&#xD;
      randomized study with 1:1 randomization and planning to enroll around 100 participants with 1&#xD;
      year follow up. One group will receive conventional cryoballoon pulmonary vein isolation, and&#xD;
      other group will receive SVC isolation after the PVI procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">July 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>efficacy</measure>
    <time_frame>one year</time_frame>
    <description>percentage of patients free of any atrial arrhythmias during the one year of follow up (occurrence of any atrial arrhythmia longer than 30 seconds, detected by Holter EKG or 12 lead EKG will be considered as treatment failure)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>feasibility</measure>
    <time_frame>during the procedure</time_frame>
    <description>the success rates of SVC isolation. percentage of patients in whom successful SVC isolation was performed. SVC isolation will be verified by the circular mapping catheter, after the application of cryoballoon lesion. The absence of electrical signals in SVC after the ablation is considered as a successful isolation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>safety</measure>
    <time_frame>one year</time_frame>
    <description>adverse events during the procedure (specials consideration on phrenic nerve palsy) and after the procedure (groin hematoma, pericardial effusion, etc)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>SVC arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who will receive SVC isolation by the means of cryoballoon after the PVI procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PVI arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who will receive convectional cryoballoon PVI procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>superior vena cava isolation</intervention_name>
    <description>SVC isolation by the means of cryoballoon</description>
    <arm_group_label>SVC arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pulmonary vein isolation</intervention_name>
    <description>conventional pulmonary vein isolation by the means of cryoballoon</description>
    <arm_group_label>PVI arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  paroxysmal atrial fibrillation scheduled for cryoballoon the ablation of atrial&#xD;
             fibrillation (indication not related to the study)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        persistent atrial fibrillation&#xD;
&#xD;
          -  renal failure&#xD;
&#xD;
          -  contrast allergy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vedran Velagic, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Hospital Centre Zagreb</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vedran Velagic, MD, PhD</last_name>
    <phone>0917929284</phone>
    <email>vvelagic@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vedran Pasara, MD</last_name>
    <phone>0917302512</phone>
    <email>vedran.pasara@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>KBC Zagreb</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vedran Velagić, MD, PhD</last_name>
      <phone>0917929284</phone>
      <email>vvelagic@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ivan Prepolec, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vedran Pasara, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <reference>
    <citation>Overeinder I, Osório TG, Călburean PA, Bisignani A, Bala G, Sieira J, Ströker E, Al Houssari M, Mojica J, Boveda S, Paparella G, Brugada P, de Asmundis C, Chierchia GB. Comparison between superior vena cava ablation in addition to pulmonary vein isolation and standard pulmonary vein isolation in patients with paroxysmal atrial fibrillation with the cryoballoon technique. J Interv Card Electrophysiol. 2021 Jan 15. doi: 10.1007/s10840-020-00932-6. [Epub ahead of print]</citation>
    <PMID>33447964</PMID>
  </reference>
  <reference>
    <citation>Wei HQ, Guo XG, Sun Q, Yang JD, Xie HY, Cao ZJ, Chen YQ, Zhang S, Wu S, Ma J. Electrical isolation of the superior vena cava using second-generation cryoballoon in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2020 Jun;31(6):1307-1314. doi: 10.1111/jce.14477. Epub 2020 Apr 11.</citation>
    <PMID>32250512</PMID>
  </reference>
  <reference>
    <citation>Iacopino S, Osório TG, Filannino P, Artale P, Sieira J, Ströker E, Bala G, Overeinder I, Hacioglu E, Călburean PA, Paparella G, Brugada P, de Asmundis C, Chierchia GB. Safety and feasibility of electrical isolation of the superior vena cava in addition to pulmonary vein ablation for paroxysmal atrial fibrillation using the cryoballoon: lessons from a prospective study. J Interv Card Electrophysiol. 2021 Mar;60(2):255-260. doi: 10.1007/s10840-020-00740-y. Epub 2020 Apr 6.</citation>
    <PMID>32253600</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 7, 2021</study_first_submitted>
  <study_first_submitted_qc>October 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Zagreb</investigator_affiliation>
    <investigator_full_name>Vedran Velagic</investigator_full_name>
    <investigator_title>MD, PhD, Assistant professor</investigator_title>
  </responsible_party>
  <keyword>pulmonary vein isolation</keyword>
  <keyword>superior vena cava isolation</keyword>
  <keyword>cryoballoon ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

